Gothenburg, Sweden

Pontus John Bergstrand

This inventor holds 2 USPTO granted patents. Top assignee: Astra Aktiebolag. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pontus John Bergstrand. Retrieved from https://idiyas.com/inventor/pontus-john-bergstrand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 130(Granted Patents)


Location History:

  • Goteborg, SE (1998)
  • Gothenburg, SE (1998)

Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pontus John Bergstrand: Innovator in Pharmaceutical Formulations

Introduction

Pontus John Bergstrand is a notable inventor based in Goteborg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents to his name, Bergstrand's work has had a meaningful impact on medication delivery systems.

Latest Patents

Bergstrand's latest patents include a "Multiple unit tableted dosage form of omeprazole" and a "Multiple unit pharmaceutical preparation." These inventions showcase his expertise in creating effective and efficient pharmaceutical formulations that enhance patient outcomes.

Career Highlights

Bergstrand is currently employed at Astra Aktiebolag, a leading company in the pharmaceutical industry. His role at Astra has allowed him to further his research and development efforts, contributing to the advancement of medication technologies.

Collaborations

Bergstrand has collaborated with various professionals in his field, including his coworker Kurt Ingmar Lovgren. These partnerships have fostered innovation and have been instrumental in the successful development of his patented technologies.

Conclusion

Pontus John Bergstrand is a distinguished inventor whose work in pharmaceutical formulations continues to influence the industry. His contributions, particularly in the area of dosage forms, highlight the importance of innovation in improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…